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Background: It is thought that a dependent relationship between patients and physicians who enroll their own
patients in research compromises voluntary informed consent. Therefore, several ethical guidelines for human
subject research provide approaches to mitigate these compromises. Currently, these approaches have not been
critically evaluated. In this article, we analyze the approaches of ethical guidelines to manage the influence of a
dependent relationship between patients and physicians on voluntary informed consent and discuss the strengths
and weaknesses of these approaches.
Methods: We performed a review of international ethical guidance documents on human subject research, listed
in the Oxford Textbook of Clinical Research Ethics and found through cross referencing. We also searched Global
Ethics Observatory (GEObs) and the World Health Organization (WHO) website. Guidelines from all years were
eligible for inclusion. The date last searched was December 2013.
Discussion: We identified two basic guideline approaches: 1. a process approach, which focuses on the person
who obtains informed consent, that is, an independent individual, such as a research nurse or counselor; and
2. a content approach, emphasizing the voluntary nature of participation. Both approaches are valuable, either
because the influence of the physician may diminish or because it empowers patients to make voluntary decisions.
However, the approaches also face challenges. First, research nurses are not always independent. Second, physician-
investigators will be informed about decisions of their patients. Third, involvement of a counselor is sometimes
unfeasible. Fourth, the right to withdraw may be difficult to act upon in a dependent relationship.
Conclusions: Current guideline approaches to protect voluntary informed consent within a dependent relationship
are suboptimal. To prevent compromises to voluntary informed consent, consent should not only be obtained by
an independent individual, but this person should also emphasize the voluntary nature of participation. At the
same time, dependency as such does not imply undue influence. Sometimes the physician may be best qualified
to provide information, for example, for a very specialized study. Still, the research nurse should obtain informed
consent. In addition, patients should be able to consult a counselor, who attends the informed consent discussions
and is concerned with their interests. Finally, both physicians and research nurses should disclose research interests.
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Ethical guidelines for human subject research assume that
voluntariness of informed consent of patients for medical
research could be compromised when their own treating
physician obtains consent [1]. Guidelines are cautious with
regard to dependent relationships between patients and
physicians. When patients depend on physicians for care
and treatment it is felt that patients may not feel free to
refuse an invitation of their physician to take part in a
study [2,3]. Patients may fear disappointing their physician
or damaging the physician/patient relationship, which
could influence their consent to research [4,5]. Several
empirical studies have shown that treating physicians can
have a considerable influence on the decision-making of
their patients with regard to research [6-12]. Many ethical
guidelines for human subject research have proposed
strategies to safeguard voluntary informed consent of pa-
tients in the case of a dependent relationship [13-21].
In this article we analyze the approaches mentioned in
the main ethical guidelines to safeguard voluntary in-
formed consent in a dependent relationship and discuss
the strengths and weaknesses of these approaches. Al-
though some scholars have touched upon issues related
to the guideline approaches, none of them has pro-
vided a systematic evaluation [3,22-25]. Ways to diminish
threats to the voluntariness of informed consent deserve
careful scrutiny, because of the widely acknowledged im-
portance of voluntary consent [1]. In addition, implemen-
ting and executing those strategies will generally mean
extra investments in terms of time and energy [1]. It is
important to know whether this time is well spent.
Methods
This article is reported according to the Methods section
of the PRISMA checklist 2009.
Protocol and registration
No review protocol exists for this study.
Eligibility criteria
We performed a review of ethical guidelines, reports
and regulations on medical research with human sub-
jects (henceforth referred to as ‘guidelines’). We only se-
lected the main international guidelines and national
guidelines that play a role in the international debate on
medical research involving human beings. Further rele-
vance of guidelines for our article was determined on
the basis of the presence of phrases that concerned the
relationship between patients and physicians in the
context of medical research, and the potential undue in-
fluence of this relationship on patient decision-making
with regard to research participation. First, guidelines
that did not mention the potential influence of the rela-
tionship between patients and physicians on voluntaryinformed consent were excluded from our analysis and
evaluation. Second, guidelines that only mentioned depen-
dent relationships and its influence, but did not provide
an approach to diminish this influence were excluded.
Third, national guidelines that were not substantially dif-
ferent from international guidelines were excluded, be-
cause they would have no added value to our evaluation
(see Figure 1).
Guidelines and regulations from all years were eligible
for inclusion in our review, since also more historic reg-
ulations are generally considered to be of relevance for
present-day analyses. Guidelines had to be written in the
English language in order to be accessible to and rele-
vant for an international audience.
Information sources
We took the Oxford Textbook of Clinical Research Ethics
[26] as a starting point. Furthermore, we searched the da-
tabases of PubMed and EMBASE to find literature to con-
duct our ethical evaluation. We also searched the Global
Ethics Observatory (GEObs) database of UNESCO and
the website of the World Health Organization (WHO).
The date last searched for all these databases was Decem-
ber 2013. We had no specific dates of coverage, since
we considered all possible publication dates of poten-
tial relevance.
Search
We started with examining the main international ethi-
cal guidelines and national guidelines that play a role in
the international debate on medical research involving
human beings, based on the Oxford Textbook of Clinical
Research Ethics which lists 16 ethical guidelines [26]. Of
these ethical guidelines, eight did not mention the eth-
ical issue of the influence of a dependent relationship
between patients and physicians on voluntary informed
consent and were excluded [27-35].
Two guidelines did mention that voluntary informed
consent could be compromised within a dependent rela-
tionship, but they both did not provide an approach to
safeguard voluntariness of patient consent and were there-
fore excluded [36,37]. Two guidelines both mentioned
dependent relationships and an approach to protect
voluntary informed consent [32,38]. However, since these
guidelines have adopted the principles of the Declaration
of Helsinki, they were not substantially different from this
major international guideline and were excluded.
The four remaining guidelines of the Oxford Textbook
of Clinical Research Ethics referred both to the influence
of a dependent relationship on voluntary informed con-
sent and suggested an approach to diminish this influence.
Hence, these guidelines were included in our analysis
and evaluation: The WMA’s Declaration of Helsinki [21];
the Council for International Organizations of Medical
Guidelines identified through 
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Figure 1 Flow diagram of the selection and inclusion of ethical guidelines.
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Biomedical Research Involving Human Subjects [13]; the
Canadian Tri-Council Policy Statement, Ethical Conduct
for Research Involving Humans [20]; and the Australian
National Health and Medical Research Council’s National
Statement on Ethical Conduct in Human Research [14].
The second part of our search was based on the me-
thod of searching for titles added by cross referencing,
since there is no one database in which all ethical guide-
lines are included. To find these additional guidelines,
we searched the references of other guidelines and of
articles discussing ethical guidelines for human subject
research. This search provided us with four additional
guidelines that conformed to our eligibility criteria: Insti-
tutional Review Boards: Report and Recommendations of
the National Commission for the Protection of Human
Subjects of Biomedical and Behavioral Research of the
United States [18]; Ethical Issues in Clinical Research in
Neurology: Advancing Knowledge and Protecting Human
Research Subjects of the Ethics and Humanities Subcom-
mittee of the American Academy of Neurology (in neu-
rology research and care are often combined, meaning
that patients are frequently recruited within a dependent
relationship) [17]; the Ethics Manual, Sixth Edition of
the American College of Physicians [19]; and ManagingConflicts of Interest in the Conduct of Clinical Trials of
the American Medical Association’s Council on Ethical
and Judicial Affairs [15].
To find further internationally important guidelines
we performed a search in ‘Database 4: Ethics Related
Legislation and Guidelines’ of the GEObs database of
UNESCO. The theme we searched within this website
was ‘Medical research with human beings’ and we in-
cluded all legal categories (that is, treaties, constitution,
domestic laws, authoritative case laws and guidelines). Fi-
nally, we searched the website of the WHO. Both the
database and the website did not provide us with add-
itional ethical guidelines that were of relevance for the
international debate on voluntary informed consent and
dependent relationships between patients and physicians.
In order to find (empirical) support for the conduct of
our evaluation of the guideline strategies, we performed
several searches in PubMed and EMBASE, using various
combinations of the following search terms: ‘dependent
relationships’, ‘dependency’, ‘physician-patient relationship’,
‘clinician-patient relationship’, ‘medical research’, ‘clinical
research’, ‘research’, ‘clinical trials’, ‘ethical guidelines’, ‘guide-
lines’, ‘policy’, ‘ethical guidance’, ‘voluntariness’, ‘voluntary
informed consent’, ‘informed consent’, ‘consent’, ‘influence’,
‘empirical’, ‘qualitative’ and ‘quantitative’.
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All included guidelines were examined for an explicit de-
scription of an approach to protect voluntary informed
consent for research when it is obtained within a de-
pendent relationship between patients and physicians.
Synthesis of results
We selected the phrases of the eight included guidelines
that expressed an approach to diminish the risk of com-
promised voluntariness due to the undue influence of
the treating relationship with and dependence upon the
physician. We derived the key aspects of each of these
guideline phrases and compared them in order to infer
whether they contained similar approaches to safeguard-
ing voluntary informed consent. We identified two basic
approaches within these ethical guidelines, that is, a pro-
cess versus a content focused approach.
With regard to the evaluation of the two guideline
approaches, we used empirical data from the studies that
showed up in our PubMed and EMBASE searches. In
addition, where empirical support was lacking our evalu-
ation is based on rational argumentation applied to the
particularities of the clinical research context.
Discussion
Defining dependent relationships, voluntary informed
consent and vulnerability
Dependent relationships
Dependency is often mentioned as a critical feature of
physician-patient relationships in clinical research, both
in the ethical guidelines for medical research with hu-
man beings [13,14,20,21] and in literature [39,40]. A de-
pendent relationship in the context of medical research
can be defined as a pre-existing treating relationship
between patients who are prospective participants and
their physicians which carries the potential for undue
influence due to the dependence of patients upon their
physicians for care and treatment [13-15,17,18,20,21]. Al-
though some national guidelines and legislations acknow-
ledge that also in the clinical context undue influence by
the physician should be avoided [41-43], we will focus on
the context of medical research.
Voluntary informed consent
All reviewed guidelines express the thought that depen-
dent relationships should be considered carefully, due to
the influence the treating physician can have on the
consent of the prospective participant. Although this
influence is not necessarily regarded as problematic, the
potential for undue influence frequently is emphasized.
The reason that undue influence is regarded undesirable
is because it compromises voluntary informed consent.
This is reflected in the definition of the Belmont Report,
which states that voluntary informed consent ‘requiresconditions free of coercion and undue influence’ [28].
Two recently suggested interpretations of voluntary in-
formed consent also regard the concept of influence as
key to their definition of voluntary informed consent,
although they speak of ‘illegitimate’ [24] and ‘controlling’
[44] influences, respectively.
Our working definition of voluntary informed consent
is the one provided by the Belmont Report [28], which
has also been accepted by the majority of the guidelines
from our analysis [13,14,17,18,20,21]. With this defi-
nition as a starting point, we are able to evaluate the
guideline approaches according to their capacity to dimi-
nish the undue influence of physicians on patients when
they recruit them for participation in medical research.
Vulnerability
To understand why patients recruited by their own phy-
sician are in need of protection by ethical guidelines, we
need to consider the concept of vulnerability. Three re-
cent accounts of vulnerability acknowledge the import-
ance of the situation or context of research participants
for attributing vulnerability [45-47]. Based on these ac-
counts we suggest that the context of a dependent relation-
ship could add an extra layer [47] or increased likelihood
of vulnerability on patients who are recruited for research,
due to the hierarchical structure [45] that is present in a
dependent relationship. Vulnerability then can be seen as a
claim to special protection [45], which strengthens the as-
sumption that additional safeguards for patients recruited
by their own physician are sensible and deserve careful
scrutiny.
For now, we consider that dependent relationships are
generally regarded as a potential source of undue influ-
ence, that undue influences compromise voluntary in-
formed consent, and that a dependent relationship may
render patients vulnerable and, therefore, in need of
special protection.
Two basic guideline approaches
It appears that ethical guidelines for medical research
with human beings suggest two different approaches to
manage the impact of a dependent relationship on vol-
untary informed consent. The first approach focuses on
the process of obtaining informed consent; the second
approach focuses on the content of the information that
is communicated to the patient (see Table 1). Most guide-
lines refer to only one of the two approaches [15,17-21],
two guidelines include both approaches [13,14].
Process approach
The informed consent process concerns two primary
activities: to inform patients of the study details and to
obtain written informed consent [21]. The first guideline
approach to diminish the influence of the dependent
Table 1 Guideline approaches to protect voluntary informed consent within a dependent relationship
Guidelines Professional association Approach
Declaration of Helsinki, 2013 World Medical Association §27: ‘When seeking informed consent for
participation in a research study the physician must
be particularly cautious if the potential subject is in
a dependent relationship with the physician or may
consent under duress. In such situations the
informed consent must be sought by an
appropriately qualified individual who is completely
independent of this relationship.’
International Ethical Guidelines for
Biomedical Research Involving Human
Subjects, 2002
Council for International Organizations of Medical
Sciences (CIOMS) in collaboration with the World
Health Organization (WHO)
Commentary on Guideline 6: ‘The physician/
investigator must assure [patients] that their decision
on whether to participate will not affect the
therapeutic relationship or other benefits to which
they are entitled. In this situation the ethical review
committee should consider whether a neutral third
party should seek informed consent.’
Tri-Council Policy Statement, Ethical
Conduct for Research Involving Humans,
2010
Canadian Institutes of Health Research, Natural
Sciences and Engineering Research Council of
Canada, and Social Sciences and Humanities
Research Council of Canada
Article 3.1 a (Application): ‘Pre-existing entitlements
to care, education and other services should not be
prejudiced by the decision of whether or not to
participate in, or to withdraw from, a research
project. Accordingly… a physician should ensure
that continued clinical care is not linked to research
participation.’
National Statement on Ethical Conduct
in Human Research, 2007
National Health and Medical Research Council,
Australia
4.3.2 ‘In the consent process, researchers should
wherever possible invite potential participants to
discuss their participation with someone who is able
to support them in making their decision.’
4.3.10 ‘Where the researcher has a pre-existing
relationship with potential participants, it may be
appropriate for their consent to be sought by an
independent person.’
Institutional Review Boards: Report and
Recommendations, 1978
The National Commission for the Protection of
Human Subjects of Biomedical and Behavioral
Research, United States
‘In cases in which the investigator is responsible for
the care of the subjects, the IRB may require that a
neutral person, not otherwise associated with
research or the investigator, be present when
consent is sought, to explain the research to
prospective subjects, or to observe the conduct of
the research … Such a person may be designated
to play a role in informing subjects of their rights
and the details of protocols, assuring that there is
continuing assent to participation, determining the
advisability of continued participation, receiving
complaints from subjects, and bringing grievances
to the attention of the IRB as part of its continuing
review of research.’
Ethical issues in clinical research in
neurology: advancing knowledge and
protecting human research subjects,
1998
The Ethics and Humanities Subcommittee of the
American Academy of Neurology, United States
‘[R]esearchers and IRBs may want to consider
additional safeguards. For example, the IRB may
request that an “uninterested” individual … discuss
with prospective subjects the research study and
other clinical or research alternatives.’
Ethics Manual, Sixth Edition, 2012 Ethics, Professionalism, and Human Rights
Committee, American College of Physicians,
United States
‘It should … be clear to patients that participation in
research is voluntary and not a requirement for
continued clinical care. The right to withdraw
consent and discontinue participation at any time
must be communicated.’
Managing Conflicts of Interest in the
Conduct of Clinical Trials, 2002
The council on ethical and judicial affairs, American
Medical Association, United States
‘[T]he physician who has treated a patient on an
ongoing basis should not be responsible for
obtaining that patient’s informed consent to
participate in a trial that will be conducted by the
physician. .. Instead … someone other than the
treating physician should obtain the participant’s
consent. The non-treating health care professional
also could remain available to answer additional
questions during the trial.’
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fied individual take over one or both of these two primary
tasks of the physician-investigator [13-15,17,18,21]. First,
this independent individual can carry out the informed
consent procedure instead of the physician-investigator
[13-15,21], to separate the informed consent process from
the therapeutic relationship [4]: ‘Where the researcher has
a pre-existing relationship with potential participants, it
may be appropriate for their consent to be sought by an
independent person’ [14]. This person, who could be
a research nurse or any other health care professional
not directly responsible for the usual care of the pa-
tient in question, should be ‘completely independent’
[21] from the treating relationship patients have with
their physician.
Second, the independent individual could explain the
study details and possible alternatives to research partici-
pation to the patients-subjects and answer the questions
patients have with regards to the provided information
[14,15,17,18]. When fulfilling these tasks, the indepen-
dent individual functions as a kind of counselor.
Content approach
The second guideline approach aims to safeguard volun-
tary informed consent within a dependent relationship
by demanding that certain vital pieces of information are
conveyed to patients. One guideline stresses that ‘the
right to withdraw consent and discontinue participation
at any time must be communicated’ [19]. One reason
why patients find it difficult to refuse participation in
the study is because they fear their refusal will adversely
affect the care they receive or the relationship with their
physician [48]. Therefore, several guidelines [13,19,20]
require from physicians that they emphasize to their pa-
tients that they will not suffer any negative consequences
from possible refusal or withdrawal from the study.
Strengths and weaknesses of both approaches
Process approach
Some positive aspects of what we have called the process
approach have been suggested in the literature. By con-
veying the task of obtaining informed consent to an in-
dependent individual, the informed consent procedure is
made more formal and clearly distinct from the practice
of caregiving [22,49]. The physician could thereby com-
municate an explicit message to the patient, emphasizing
the difference between research and usual practice [3,22].
To delegate the informed consent process to an in-
dependent individual is important in order to avoid pa-
tients feeling intimidated by their physician [25]. It is
mentioned that research nurses (or other study coor-
dinators) are considered to be more neutral than phy-
sicians and researchers, making them better suited to
obtain patient informed consent [11] since they are notdirectly involved with the usual care of the patients [49].
Their neutrality arises because they are independent from
the treating relationship between patients and physi-
cians. Since guidelines regard dependent relationships
as problematic, this initial neutrality of the research nurse
is thought to diminish the potential undue influence of
the physician on patient decision-making [2,49].
However, considerable demands are often placed upon
research nurses to recruit and retain a high number of
patients to meet the study targets [50,51], and some-
times their employment depends upon their succeeding
to complete trials in order to gain funding for subse-
quent studies. Therefore, it is questionable how neutral
the position of research nurses actually is.
In addition, research nurses are frequently not as inde-
pendent from the treating relationship with patients as
is suggested. Although there is no generally accepted,
standardized description of the tasks of the clinical re-
search nurse [52], an important aspect of their role is
that in addition to their research related tasks, they are
usually also involved in the care of the patients they have
recruited for research [51]. Clinical research nurses mo-
nitor the participating patients, explaining additional de-
tails, providing support and carrying out the distribution
of medication [53,54]. Therefore, they must find a bal-
ance between the needs of patients and the demands of
the research protocol [55]. Qualitative studies have shown
that research nurses themselves experience such a role
conflict [50,51,54], although they generally feel that their
role as patient advocate is their primary one [54].
The caregiving role of research nurses entails ongoing
interaction with patients, which could result in a rela-
tionship between research nurses and the patients they
take care of [50,54], similar to the dependent relation-
ship between patients and physicians. A risk of such a
relationship is that patients feel they are in some way
dependent upon the research nurse, leading patients to
think they should follow the nurse’s recommendations
[54]. This could in turn prevent them from withdrawing
from the study, which is contrary to the demand that
voluntary informed consent needs to be protected both
at the start of the study and as the study progresses [1].
In addition to factors specifically applying to the re-
search nurse, several other challenges to the process
approach can be assumed. The strategy to have an inde-
pendent individual obtain informed consent instead of the
treating physician starts from the assumption that such a
person makes it easier for patients to refuse. However, two
aspects of clinical research practice should be considered
to assess the potential effectiveness of having a third
person obtain consent.
First, the independent person is usually invited by the
physician-investigator or appointed by the hospital where
the patient is treated [23]. As a result, patients may not
Dekking et al. BMC Medicine Page 7 of 112014, 12:52
http://www.biomedcentral.com/1741-7015/12/52perceive this supposedly independent person as truly in-
dependent from the relationship they have with their
physician. Therefore, this person could just as well unduly
influence the consent of the prospective participant.
Second, even though an independent individual ob-
tains the informed consent of patients, several situations
exist in which the physician of these patients will also be
notified of their decision. When patients express their
refusal to the independent individual, their own phys-
ician who conducts the study in question will typically
be informed of this decision [23] since he or she needs
to know whether the patient participates in the study or
should receive standard treatment. In a dependent situ-
ation the treating physician will always know whether
the patient declined or accepted research participation,
because this physician is the one who both conducts the
study and has the responsibility for the treatment of the
patient. So, the influence of the dependent relationship
is not removed, meaning that some patients still consent
against their wishes because their physician will know
anyhow.
Furthermore, even when the treating physician is not
involved with the study the patient is included in, it will
in some situations still be necessary to inform the phy-
sician of the decision of their patient. For instance, in
case research participation influences the usual care or
when during the trial clinical problems arise that should
be dealt with by the physician [23]. Thus, the decision of
whether a participant has given consent is always dis-
closed, irrespective of possible blinding of the physician
for the study drug that a patient will receive if the pa-
tient has given consent. It is the disclosure of the deci-
sion to participate that is relevant in light of threats to
voluntariness.
The use of counselors to support patients in decision-
making and empower patients to choose their preferred
option seems a useful way to improve voluntary consent
[54], since they should be able to ask relevant questions
and provide support to patients [25]. However, a chal-
lenge for this approach emerges when counselors lack
medical expertise [25]. This will especially be the case if
the counselor is a friend or relative [23].
Another challenge to the involvement of counselors is
mainly practical. It will be difficult for many hospitals or
other health care facilities to train and appoint a suffi-
cient number of counselors to provide support for the
large number of patients that is recruited within a
dependent relationship.
Support of counselors or of other kinds of representa-
tives is not unique for the context of dependent relation-
ships. Several ethical guidelines also propose advocates
or counselors for patients with insufficient mental
capacity to consent on their own [13,14,20,21]. A factor
that is often mentioned is that these advocates shouldconsider the interests and preferences of the prospective
participant in question [14,20].
Interestingly, in describing the role of the counselor
who supports patients in dependent relationships, ethical
guidelines merely state that these counselors should pro-
vide study details, be available for questions during and
after the informed consent procedure and assess the ad-
visability of further participation. As such, the guidelines
do not explicitly mention that counselors should take
the interests and preferences of patients into account.
Content approach
The rights to withdraw and refuse and the absence of
negative consequences should also always be communi-
cated to patients recruited outside the context of a de-
pendent relationship to emphasize the voluntary nature
of research participation [21,35]. Without this informa-
tion, not all patients will be aware of their rights to
refuse and withdraw without any retribution, which
would be an ethically undesirable situation and would
mean an infringement upon the validity of informed
consent [56].
However, the positive effects of the content approach
on patients in a dependent relationship have hardly been
studied. We think that this results from the content
approach not previously being identified as one of two
approaches to protect voluntary informed consent in a
dependent relationship: most scholars and studies focus
on introducing an independent individual in the informed
consent procedure and more specifically on the role of the
research nurse.
Therefore, advantages of the content approach are not
readily supported by the literature. Although one study
shows that some data managers (for example, research
nurses, research assistants, study coordinators) feel that
presenting information in a non-coercive manner and
making patients aware of their rights to refuse and with-
draw could ensure voluntary participation [25], it is un-
clear how patients perceive this. Arguably, conversations
with a research nurse or some other member of the
research team could provide patients with robust know-
ledge [57], which could aid them with their decision-
making. Yet, at least two challenges remain for the content
approach.
First, statements on the right to withdraw and the ab-
sence of negative consequences can easily become void
expressions rather than effective ways to protect the vol-
untary informed consent. The disclosure of information
is not sufficient to meet the requirements for informed
consent [25], since patients should also understand the
information they receive [58]. The manner in which the
physician communicates the information is of great im-
portance for patient comprehension [58], something that
ethical guidelines currently do not incorporate.
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that at least 75% of research participants are generally
aware of their right to withdraw [59], in certain contexts a
gap exists between knowing something and acting upon it
[60]. Understanding information on voluntariness does
not equal voluntary informed consent. A recent study by
Horwitz et al. tried to untangle comprehension and
voluntariness in the informed consent process for a HIV
trial in Haiti [61]. They found that even though the parti-
cipants showed good understanding of the study details,
including the voluntary nature of the study, 11% gave
responses suggesting involuntary consent. One of these
responses concerned the belief ‘that a “volunteer” is some-
one who makes an irreversible commitment to remain in
the study’ [61].
This study shows that even patients who had under-
stood the provided information did not realize that they
were indeed free to withdraw at any moment. For pa-
tients within a dependent relationship, the gap between
knowing and acting upon that knowledge may be even
greater, since patients depend upon their physician for
the provision of care and treatment. Thus, although
patients know and understand their rights, they could be
hesitant to withdraw from the study even though they
know they have the right to, since they do not want to
disappoint their treating physician [22].
Moving forward
The approaches as suggested by ethical guidelines seem
suboptimal safeguards with respect to the voluntariness
of informed consent in a dependent relationship. First,
the influence of the physician is not necessarily suffi-
ciently diminished when someone else obtains informed
consent. Second, the right to withdraw cannot suffi-
ciently be protected by simply pointing at this right
and this right may be difficult to act upon in a dependent
relationship.
It is time that physicians, investigators and members
of Research Ethics Committees acknowledge that cur-
rent guideline approaches do not appropriately protect
patients who are enrolled by their own physician. More-
over, we believe that quick and easy solutions to the
problem of compromised voluntariness do not exist. At
least, the two existing approaches should be combined.
The content approach, although on its own not suffi-
cient, is of pivotal importance. Patients should always be
informed about the voluntary nature of research partici-
pation and about the absence of negative consequences
when they refuse or withdraw. And as regards the pro-
cess approach, it is not sufficient if obtaining informed
consent is delegated to a presumed neutral third party,
since these persons are often not independent, both of
the treating relationship and of the study in question. At
the same time, feasible inclusion by the research nurseor an equally qualified person is preferred over inclusion
by the treating physician, since this physician is the
primary caregiver.
However, a dependent relationship does not always
imply compromised voluntariness of informed consent
of the patients who are recruited for research by their
own physician. People are influenced by others all the
time and not all influences necessarily pose a threat to
voluntary informed consent [24,44]. Consequently, being
in a dependent relationship does not imply that patients
should make decisions about research participation com-
pletely independent from the physician. Moreover, in
some dependent situations it can be preferable that the
physician provided the patient with information instead
of the research nurse, for instance, if the research is the
means through which treatment is delivered or if a study
is too detailed and specialized for research nurses to
explain. The informed consent can then be signed in
the presence of a research nurse or an equally quali-
fied colleague.
In the clinical context the relevance of social relation-
ships for decision-making has already been recognized,
since ‘preferences developed independently are not ne-
cessarily better than treatment preferences developed in
collaboration’ [62]. One could also argue that in the con-
text of medical research, patients appreciate being in-
formed by their own physician, if patients feel they know
and trust this person and feel comfortable speaking to
their physician. For instance, a review by McCann et al.
has shown that patients consider the interaction with
their physician as key to their research involvement [63],
indicating that a supportive and active role with their
physician is something that patients find valuable when
deciding about research.
Although caution in the case of a dependent relation-
ship is still required, an existing dependent relationship
should not by definition prevent a supportive and en-
gaged role of physicians, as long as they are aware of
their potential influence and ‘recognize how their inter-
actions and relationships with patients can either enable
or impair patients’ autonomy’ [64]. So, the challenge for
physicians is to be engaged and supportive, without un-
duly influencing their patients. If physicians approach
their own patients for research they should find a balance
between undue influence at one end of a continuum and
independent decision-making on the other end. They
should be honest and transparent about their research
related interests and should give responsive support
adapted to individual patients and their needs, prefer-
ences and abilities [62]. These requirements equally apply
to research nurses who cannot be independent.
Where feasible, patients should be able to ask for addi-
tional protection by involving a counselor. This is true also
in case it is the research nurse who obtains informed
Dekking et al. BMC Medicine Page 9 of 112014, 12:52
http://www.biomedcentral.com/1741-7015/12/52consent. Although some guidelines suggest that patients
should be in the position to discuss research participation
and the study details with someone else [14,15,17,18], the
guidelines do not elaborate on what his or her role exactly
is. We suggest that this counselor should be independent
(for example, a regular nurse who works in a different
department and is not involved in the study), specifically
educated and be able to support patients in their decision-
making. Therefore, on the patient’s request, this counselor
should be present during informed consent discussions.
He or she should pay close attention to the preferences
and views of patients in order to enable them to make de-
cisions that fit their goals and values. Also, the counselor
should be available to answer any questions patients might
have afterwards or during the proceedings of the trial.
Further research
In order to effectively reflect on the interaction between
patients and their physicians during the informed con-
sent procedure and develop an approach that respects
medical research practice, more research is needed. First,
we need to know whether patients indeed feel pressure
to accept an invitation for research from their physician
due to the prior therapeutic relationship. Second, if vol-
untary informed consent is compromised when obtained
within a dependent relationship, it should be investi-
gated how extensive the problem is and which factors
contribute to it. Factors that could be of importance are
whether physicians recruit patients for their own re-
search or for someone else’s [15,17]. Furthermore, the
degree of dependency [20] can be of importance, which
in turn can be influenced by the severity of the disease
[40] and the length of the treating relationship [17].
Third, the merits of our new proposal, that is, a combin-
ation of the process and content approaches comple-
mented by an upgraded version of the counselor, should
be empirically studied, taking the perspectives and expe-
riences of patients and physicians into account.
Conclusions
Ethical guidelines try to manage the impact of a de-
pendent relationship on voluntary informed consent in
two ways. One approach focuses on the process of ob-
taining informed consent; the other on the content of
the information that is communicated to the patient.
Some guidelines include both approaches; other guide-
lines only articulate one of them. Our analysis shows
that although both approaches could have some favor-
able impact on voluntary informed consent of patients,
they also face challenges. Research nurses are not inde-
pendent of the treating relationship patients have with
their physician, since they frequently provide care to the
included patients. Also, they are not neutral with regard
to the study they recruit patients for, as their job oftendepends on assuring high inclusion rates. Any other
health care professional is likely to be regarded by pa-
tients as belonging to the team of the physician, which
could also influence voluntary informed consent.
Furthermore, even if patients express their refusal to
an independent individual, in many instances their own
physician will be informed of this decision, which means
that the influence of the physician on voluntary informed
consent is still present. Making patients aware of their
rights to refuse and withdraw at any time is important,
but might not be convincing for patients enrolled by their
own physician, because they depend on the physician for
care and treatment.
At least the process and content approach should be
combined. Patients in a dependent relationship should
in all instances be informed of their rights to withdraw
and refuse without any negative consequences with regard
to their care or the relationship with their physician. Fur-
thermore, inclusion by a research nurse is preferred over
inclusion by the physician, since the physician is the pri-
mary caregiver of the patients. Deviations from this rule
are conceivable in cases where research is part of the
treatment or where a physician will be better able to ex-
plain the research protocol than the research nurse. After
all, dependency as such does not imply undue influence.
Patients need not make completely independent decisions
in order for these decisions to be voluntary. In such cases,
it is important that physicians are aware of their own in-
fluence and be transparent and honest about their existing
research interests. This is also the case for research nurses
who cannot be independent.
To further prevent undue influence, patients should be
able to ask for a specifically educated and independent
counselor, who can attend the informed consent process.
This should also be the case if the research nurse obtains
informed consent. These counselors should be in the
position to provide support to patients and optimally
safeguard voluntary informed consent, if they actively
take the values and preferences of patients into account.
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